Literature DB >> 24107276

Solute removal capacity of high cut-off membrane plasma separators.

Atsushi Ohkubo1, Naoki Kurashima, Ayako Nakamura, Satoko Miyamoto, Soichiro Iimori, Tatemitsu Rai.   

Abstract

In vitro blood filtration was performed by a closed circuit using high cut-off membrane plasma separators, EVACURE EC-2A10 (EC-2A) and EVACURE EC-4A10 (EC-4A). Samples were obtained from sampling sites before the plasma separator, after each plasma separator, and from the ultrafiltrate of each separator. The sieving coefficient (S.C.) of total protein (TP), albumin (Alb), IgG, interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), fibrinogen (Fib), antithrombin III (AT-III), and coagulation factor XIII (FXIII) were calculated. The S.C. of each solute using EC-2A and EC-A4 were as follows; TP: 0.25 and 0.56, Alb: 0.32 and 0.73, IgG: 0.16 and 0.50, IL-6:0.73 and 0.95, IL-8:0.85 and 0.82, TNF-α: 1.07 and 0.99, Fib: 0 and 0, FXIII: 0.07 and 0.17, respectively. When compared with the conventional type of membrane plasma separators, EVACURE could efficiently remove cytokines while retaining coagulation factors such as fibrinogen. Moreover, EC-2A prevented protein loss, whereas EC-4A could remove approximately 50% of IgG.
© 2013 The Authors. Therapeutic Apheresis and Dialysis © 2013 International Society for Apheresis.

Entities:  

Keywords:  Cytokine; Membrane plasma separator; Plasma exchange therapy; Pore size; Sieving coefficient

Mesh:

Substances:

Year:  2013        PMID: 24107276     DOI: 10.1111/1744-9987.12114

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  2 in total

1.  Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.

Authors:  Mayuko Kawabe; Izumi Yamamoto; Ai Katsuma; Naomi Hayashi; Yo Komatsuzaki; Yasuyuki Nakada; Akihiro Shimizu; Yudo Tanno; Ichiro Ohkido; Nobuo Tsuboi; Kazuhito Suzuki; Takaki Shimada; Yoji Ogasawara; Katsuki Sugiyama; Keisuke Aiba; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2016-08-11

2.  Selective plasma exchange in ABO-incompatible kidney transplantation: comparison of substitution with albumin and partial substitution with fresh frozen plasma.

Authors:  Ako Hanaoka; Toshihide Naganuma; Daijiro Kabata; Yoshiaki Takemoto; Junji Uchida; Tatsuya Nakatani; Ayumi Shintani
Journal:  Sci Rep       Date:  2020-01-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.